Dr Morena Sallabanda

CV of Dr. Morena Sallabanda Hajro, MD, PhD, MSc

Dr. Morena Sallabanda is a Radiation Oncologist at IRCA and complements her professional work at the Proton Therapy Center of Quirón Salud.

She studied Medicine and Surgery in Madrid, at the Universidad Complutense de Madrid and at the Hospital General Universitario Gregorio Marañón, receiving her doctorate in 2021 after a 5-year research thesis.

During that time he also completed the Master in Radiosurgery, of which, over the years he has ended up contributing his experience and participating as a teacher.

His experience as a specialist in Radiation Oncology is extensive, having held this position within the entity Genesis Care in emblematic hospitals such as the Milagrosa Hospital in Madrid and the Cyberknife Unit in Madrid.

He completed his residency in Radiation Oncology at the Hospital Universitario Puerta de Hierro in Majadahonda.

His foreign career includes,

• Proton Therapy at the Penn Medical University Health System of Pennsylvania, Philadelphia, U.S.A.
• Radiation Oncology Rotation at Massachusetts General Hospital, Boston, U.S.A.

Dr. Morena speaks 5 languages: English, Italian, French, and as a native speaker, Spanish and Albanian.

🩺 Innovation in IRCA and the ZAP-x technology in which Dr. Morena is part of

As we have pointed out on different occasions, the ZAP-x technology used in IRCA is technologically advanced and does not generate polluting waste.

If you would like more information about this innovation, please click on this link

 

However, this has not always been the case in the field of radiosurgery in the past.

Therefore, among her many areas of expertise within this field, Dr. Morena got her training as a Radioactive Facilities Supervisor in 2016. As we say, in IRCA it is not precise.

 

🩺 Academic Background

🔵PhD in Medicine at Complutense University of Madrid. Dr. Morena Sallabanda obtains her PhD degree in January 2021 with distinction CUM LAUDE.

🔵 The doctoral topic was OLIGOMETASTIC SURVIVORS: SOCIOSANITARY DEPENDENCE POST INTENSIVE CRANEAL CRANEAL THERAPY. The doctoral thesis directors were Felipe Calvo Manuel, María Isabel García Berrocal.

🔵International Master in Central Nervous System Radiosurgery June 2019 at the Complutense University of Madrid.

🔵 Internship in Gammaknife unit (Hospital Ruber Internacional) and Cyberknife unit (Genesis Care, Madrid). Part of the master’s degree faculty in the 2019-2020, 2020-2021 and 2021-2022 editions.

🔵Degree + Master in Medicine at Universidad Complutense de Madrid 2007-2013
2012: 5-week external rotation: Massachusetts General Hospital, Boston, MA. Radiation Oncology Department.
2011-2013: Collaborator in Oncology Department (Radiation Oncology Service) at Hospital Universitario Gregorio Marañón.

🩺Work Experience

🔵Dr. Moreno is currently a Medical Specialist in Radiation Oncology at the Institute of Advanced Radiosurgery (IRCA).

🔵She also holds this position of Medical Specialist in Radiation Oncology currently at Centro de Protonterapia Quirónsalud.

🔵Physician Specialist in Radiation Oncology June 2019 – September 2021 Genesis Care Cyberknife Unit Madrid
Unit Coordinator since October 2019.

🔵Physician Specialist in Radiation Oncology June 2018 – May 2019
Genesis Care Tomotherapy Unit Hospital La Milagrosa Madrid
Genesis Care Toledo – Guadalajara

🔵Intern Resident Physician in Radiation Oncology May 2014 – May 2018
Hospital Universitario Puerta de Hierro Majadahonda

🔵 External Rotation at University Hospital of Philadelphia: PENN MEDICINE. September – October 2017
Protontherapy Center (IBA Protontheray), Gammaknife and Cyberknife.
🔵External rotation in Brachytherapy at Hospital Clínico San Carlos April – June 2017
High rate brachytherapy in prostate, gynecological and breast tumors.

Professional Competencies

– Intensity Modulated Radiation Therapy (IMRT), Image Guided Radiation Therapy (IGRT).
– Stereotactic Body Radiotherapy (SBRT), Fractionated Stereotactic Radiotherapy and CNS Radiosurgery in Novalis units (BrainLab), Cyberknife, Gammaknife, Tomotherapy, ZAP-X and Protontherapy.
– Protontherapy.
– Intraoperative Radiotherapy (IORT).
– High rate brachytherapy.
– Total Skin Irradiation (TSI).
– Total Body Irradiation (TBI).
– Conformal External Radiation Therapy (3DCRT).

🩺Academic Achievements included in Dr. Morena Sallabanda’s CV

COLLABORATION IN BOOK CHAPTERS

• Sallabanda K, Sallabanda M, Gerszten P. Intradural spinal lesions (2020). In Conti A, Romanelli P, Pantelis
• E, et al. CyberKnife NeuroRadiosurgery. A practical guide (1st ed., pp 473-483). Springer Nature Switzerland.
• Sallabanda K, Sallabanda M, Garcia R, Calvo FA. Radiosurgery in brain metastases (2019).
• Sallabanda K, Radiosurgery. Fundamentals, technological advances, indications and results (2nd ed., pp 317-336). Madrid: Aran.
• Yañez ML, Mehta M, Sallabanda M, Sallabanda K. Radiosurgery as salvage treatment of high-grade brain gliomas (2019). In Sallabanda K, Radiosurgery. Fundamentals, technological advances, indications and results (2nd ed., pp 337-350). Madrid: Aran

PUBLICATIONS IN INTERNATIONAL JOURNALS

The following are the publications made by Dr. Morena Sallabanda:

1. Lovo EE, Moreira A, Barahona KC, Ramirez J, Campos F, Tobar C, Caceros V, Sallabanda M, Sallabanda
   K. Stereotactic Radiosurgery for Recurrent Glioblastoma Multiforme: A Retrospective Multi-Institutional
   Experience. Cureus. 2021 Oct 4;13(10):e18480. doi: 10.7759/cureus.18480.
2. Sallabanda M, Garcia R, Lorenzana L, Santaolalla I, Abarca J, Sallabanda K. Treatment of Chordomas
   and Chondrosarcomas With CyberKnife Robotic Hypofractionated Radiosurgery: A Single Institution
   Experience. Cureus. 2021 Aug 8;13(8):e17012. doi: 10.7759/cureus.17012.
3. Sallabanda K, Sallabanda M, Barrientos HD, Santaolalla I, Garcia R. Trigeminal Trophic Syndrome
   Secondary to Refractory Trigeminal Neuralgia Treated with CyberKnife® Radiosurgery. Cureus.
   2020;12(4):e7670. Published 2020 Apr 14. doi:10.7759/cureus.7670
4. Sallabanda M, García-Berrocal MI, Romero J, García-Jarabo V, Expósito MJ, Rincón DF, Zapata I,
   Magallón MR. Brain metastases treated with radiosurgery or hypofractionated stereotactic radiotherapy:
   outcomes and predictors of survival. Clin Transl Oncol. 2020 Mar 2. doi: 10.1007/s12094-020-02321-x.
5. Sallabanda K, Yañez L, Sallabanda M, Santos M, Calvo FA, Marsiglia H. Stereotactic Radiosurgery for the
   Treatment of Recurrent High-grade Gliomas: Long-term Follow-up. Cureus. 2019 Dec 31;11(12): e6527. doi:
   10.7759/cureus.6527.
6. García R, Sallabanda K, Santa-Olalla I, Lopez JL, Aviles L, Sallabanda M, Rivin E, Samblas J. Robotic
   Radiosurgery for Treatment of Intramedullary Spinal Cord Metastases: A Case Report and Literature Review.
   Cureus 2016;8(5):e609. doi: 10.7759/cureus.609.
7. Krengli M, Calvo FA, Sedlmayer F, Sole CV, Fastner G, Alessandro M, Maluta S, Corvo R, Sprek E, Litoborski M, Pisani C, Fusconi F, Osti MF, Tomio L, Marsiglia H, Ciabattoni A, Polkowski W, Di Grazia A, Kuten A, Iotti C, Gonzalez C, Sallabanda M, Dubois JB, Catalano G, Valentini V. Clinical and technical characteristics of intraoperative radiotherapy. Analysis of the ISIORT-Europe database. Strahlenther Onkol. 2013;189(9):729-37.
   doi: 10.1007/s00066-013-0395-1.
8. Calvo FA, Alonso-Murillo L, Sallabanda M, Villanueva-Martinez J, Herranz R, Sole CV. Intraoperative Radiation Therapy, opportunities for clinical practice normalization: MEDTING, a Scientific Platform. Rep Pract Oncol Radiother. 2013;19(4):253-8. doi: 10.1016/j.rpor.2013.08.009.
9. Calvo FA, Sallabanda M, Sole CV, Gonzalez-San Segundo C, Alonso-Murillo L, Villanueva-Martinez J.
   Intraoperative Radiation Therapy Opportunities for Clinical Practice Normalization: Data Recording and Innovative Development. Rep Pract Oncol Radiother. 2013;19(4):246-52. doi: 10.1016/j.rpor.2013.07.010.4
10. Calvo FA, Alonso-Murillo L, Sallabanda M, Villanueva-Martínez J, Pascau J, Sole CV. Imaging opportunities for treatment planning in intraoperative electron beam radiotherapy (IOERT): Developments in the context of RADIANCE system. Rep Pract Oncol Radiother. 2013;19(4):239-45.

Dr. Morena Sallabanda’s CV also includes:

• Papers presented at national and international congresses (ESTRO, SEOR, SER): 15 papers between 2015 and 2023.
• Training course for supervisors of radioactive facilities in the field of radiotherapy with obtaining training certificate. CIEMAT. May 2016.
• Participation in more than 20 continuing education courses (2014-2020).

In this link you can visit the professional profile of Dr. Morena Sallabanda in LinkedIn.